| Income Statement |
| Total Revenue | 3.21B |
|
| Revenues (USD) | 465.23M |
| Cost of Revenue | 745.17M |
| Gross Profit | 2.46B |
| Operating Expenses | 1.92B |
| Research and Development Expense | 125.46M |
| Selling, General and Administrative Expense | 606.29M |
| Operating Income | 546.84M |
| Interest Expense | 17.15M |
| Income Tax Expense | 93.12M |
| Net Income | 415.06M |
| Net Income Common Stock | 415.06M |
| Net Income Common Stock (USD) | 60.15M |
| Consolidated Income | 421.06M |
| Net Income to Non-Controlling Interests | 6.00M |
| Earnings per Basic Share | 1.75 |
| Earnings per Basic Share (USD) | 0.25 |
| Earnings per Diluted Share | 1.65 |
| Earning Before Interest & Taxes (EBIT) | 525.33M |
| Earning Before Interest & Taxes (USD) | 76.13M |
| Weighted Average Shares | 1.19B |
| Weighted Average Shares Diluted | 1.28B |
| Balance Sheet |
| Cash and Equivalents | 6.55B |
| Cash and Equivalents (USD) | 949.37M |
| Investments | 10.75B |
| Trade and Non-Trade Receivables | 2.98B |
| Property, Plant & Equipment Net | 675.80M |
| Total Assets | 25.69B |
| Total Debt | 1.37B |
| Total Liabilities | 9.14B |
| Accumulated Retained Earnings (Deficit) | 11.96B |
| Accumulated Other Comprehensive Income | 38.08M |
| Shareholders Equity | 16.25B |
| Shareholders Equity (USD) | 2.35B |
| Total Debt (USD) | 199.15M |
| Deferred Revenue | 1.13B |
| Goodwill and Intangible Assets | 350.01M |
| Trade and Non-Trade Payables | 974.77M |
| Tax Assets | 3.22B |
| Tax Liabilities | 1.22B |
| Cash Flow |
| Net Cash Flow from Financing | 9.42M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 352.68M |
| Net Cash Flow from Investing | 146.02M |
| Net Cash Flow from Operations | 225.99M |
| Effect of Exchange Rate Changes on Cash | -28.75M |